Goldman Sachs Advises Shareholders To Sell And Buy Their Stakes In These Firms

Retrieved on: 2024-04-17 14:38:59

Tags for this article:

Biocon

Pharmaceutical industry in India

Laurus Labs

Goldman Sachs

Contract manufacturing organization

Pharmaceutical industry in China

Click the tags to see associated articles and topics

Goldman Sachs Advises Shareholders To Sell And Buy Their Stakes In These Firms. View article details on HISWAI: https://www.news18.com/business/goldman-sachs-advises-shareholders-to-sell-and-buy-their-stakes-in-these-firms-8854727.html

Summary

Goldman Sachs's investment advice reflects a strategic shift favoring companies like Syngene International that may benefit from the "China+1" business strategy, enhancing their position in the global pharmaceutical industry including markets like India.

Article found on: www.news18.com

View Original Article